COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 5,995.00
-17.00 (-0.28%)
Jun 19, 2026, 3:30 PM JST
COSMOS Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Net Income | 42,372 | 33,719 | 32,773 | 33,048 | 38,596 |
Depreciation & Amortization | 22,229 | 19,924 | 17,368 | 15,110 | 13,785 |
Loss (Gain) From Sale of Assets | 508 | 937 | 113 | -195 | -4,159 |
Other Operating Activities | -9,586 | -8,646 | -9,034 | -13,188 | -9,090 |
Change in Accounts Receivable | -123 | -185 | -254 | -97 | 8 |
Change in Inventory | -6,182 | -8,704 | -11,156 | -5,853 | -7,006 |
Change in Accounts Payable | -2,423 | 17,697 | 22,627 | 6,183 | -3,491 |
Change in Other Net Operating Assets | 5,672 | 433 | 1,997 | -2,814 | -768 |
Operating Cash Flow | 52,467 | 55,175 | 54,434 | 32,194 | 27,875 |
Operating Cash Flow Growth | -4.91% | 1.36% | 69.08% | 15.49% | -57.42% |
Capital Expenditures | -53,326 | -55,810 | -46,636 | -43,497 | -26,064 |
Sale of Property, Plant & Equipment | - | 718 | 46 | 1,519 | 8,677 |
Other Investing Activities | -2,122 | -2,237 | -2,523 | -1,739 | -1,994 |
Investing Cash Flow | -55,448 | -57,329 | -49,113 | -43,717 | -19,381 |
Long-Term Debt Issued | 20,000 | 18,400 | 10,000 | 300 | - |
Long-Term Debt Repaid | -5,082 | -3,193 | -1,628 | -1,486 | -1,486 |
Net Debt Issued (Repaid) | 14,918 | 15,207 | 8,372 | -1,186 | -1,486 |
Repurchase of Common Stock | -2 | - | - | -2 | - |
Common Dividends Paid | -4,959 | -4,659 | -3,266 | -3,266 | -2,277 |
Other Financing Activities | -2,240 | -2,021 | -1,861 | -1,768 | -1,744 |
Financing Cash Flow | 7,717 | 8,527 | 3,245 | -6,222 | -5,507 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -2 |
Net Cash Flow | 4,736 | 6,373 | 8,566 | -17,745 | 2,985 |
Free Cash Flow | -859 | -635 | 7,798 | -11,303 | 1,811 |
Free Cash Flow Growth | - | - | - | - | -95.42% |
Free Cash Flow Margin | -0.08% | -0.07% | 0.94% | -1.50% | 0.25% |
Free Cash Flow Per Share | -10.84 | -8.01 | 98.46 | -142.72 | 22.87 |
Cash Interest Paid | 258 | 101 | 51 | 52 | 60 |
Cash Income Tax Paid | 9,571 | 8,993 | 9,111 | 13,337 | 9,103 |
Levered Free Cash Flow | -6,530 | -7,985 | 5,044 | -15,323 | -2,005 |
Unlevered Free Cash Flow | -6,372 | -7,923 | 5,076 | -15,291 | -1,967 |
Change in Working Capital | -3,056 | 9,241 | 13,214 | -2,581 | -11,257 |